Abstract
Introduction

Common variable immunodeficiency (CVID) is a clinically and immunologically heterogeneous disorder. Its etiology is unknown and it is essentially characterized by deficient immunoglobulin production and hypogammaglobulinaemia, usually accompanied by decreased serum IgG and IgA levels. About one-half of patients with CVID show Tcell dysfunction including decreased proliferative responses to T-cell receptor stimulation and impaired expression of interleukin-2 (IL-2) and other cytokines (1). Reduced percentages of peripheral B-cells have been described in some subjects with CVID, although there is no convincing evidence for any intrinsic B-cell defect in immunoglobulin synthesis or secretion; however, accelerated peripheral B-cell apoptosis has been demonstrated for some CVID patients
. CVID is the most common symptomatic primary antibody immunodeficiency syndrome in our region and affects both males and females. Its prevalence has been estimated at 1: 10,000 to 1: 50,000 (1) .
This syndrome typically presents as early, recurrent pyogenic infections, particularly in the sinopulmonary and gastrointestinal tracts, and is accompanied by a wide constellation of autoimmune, malabsorptive and neoplastic processes (2). Other infections, suggestive of severe T-cell defects, including
Pneumocystis jiroveci, chronic candidiasis, and recurrent orofacial herpes, have been reported in a few patients (2) . Symptoms may start at any time from childhood, with the onset most often between the second and third decades of life. Association with multisystemic granulomatous disease is a well-documented complication of CVID, and it is estimated that up to 22% of these patients present sarcoid-like non-caseating epithelioid granulomas in lym-F i g u r e 1 . L i v e r p a r e n c h y ma wi t h f i b r o u s p r o l i f e r a t i o n i n t h e p o r t a l t r a c t a n d d e n s e , mi x e d i n f l a mma t o r y i n f i l t r a t i o n a f f e c t i n g b i l i a r y d u c t s . T h e d e t a i l s h o ws a mu l t i n u c l e a r g i a n t c e l l o f t h e L a n g h a n s ' t y p e ( t r i c h r o me s t a i n , × 2 0 0 a n d × 4 0 0 ) .
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phoid tissues, solid organs, or skin (3) (4) (5) (6) 
F i g u r e 3 . Ch e s t c o mp u t e d t o mo g r a p h y ( CT ) s c a n s h o wi n g b i l a t e r a l c y l i n d r i c a l b r o n c h i e c t a s i s p r e d o mi n a n t l y i n t h e l o we r l o b e s .
F i g u r e 4 . Ab d o mi n a l c o mp u t e d t o mo g r a p h y ( CT ) s c a n s h o wi n g h o mo g e n e o u s h e p a t o s p l e n
o me g a l y a n d mi n i ma l r e t r o p e r i t o n e a l l y mp h n o d e e n l a r g e me n t . (Fig. 3) accompanied by homogeneous hepatosplenomegaly and retroperitoneal lymph node enlargement (the largest node was 1.2 cm) (Fig. 4) . In order to discard an underlying infectious or neoplastic condition (gastric or lymphoproliferative), samples were obtained from the duodenum and bone marrow, confirming the presence of noncaseating granulomas with no evidence of infection or malignancy (Fig. 5) . The microbiological processing of the samples for fungi, parasites and mycobacterium was negative (Ziehl-Neelsen, periodic acid-
F i g u r e 5 . B o n e ma r r o w wi t h n o r ma l h a e ma t o p o i e t i c t i s s u e , d i s p l a c e d i n s o me a r e a s b y e p i t h e l i o i d g r a n u l o ma s wi t h mi n i ma l n e c r o t i c f o c i . Hi g h e r ma g n i f i c a t i o n s h o ws a n i n c o m p l e t e g r a n u l o ma
Schiff and silver stains), as were the immunohistochemistry (IHC) analyses for human herpes virus type 8 (HHV8). Bone marrow culture for Leishmania spp. on Novy-McNealNicolle (NNN) medium was also negative. The transthoracic echocardiography showed no images suggestive of valvular vegetations. A gallium-67 citrate whole-body scan also revealed no sign of pathological tracer uptake, with the exception of the mild hepatomegaly. Two consecutive angiotensinconverting enzyme (ACE) determinations showed a level rise from 30.9 to 87.3 U/l (normal: 8-52 U/l). The 24-hour urinary calcium excretion was 40 mg (normal: 0-300 mg). With the suspicion that the underlying cause of the febrile syndrome was a sarcoidosis-like or granulomatous form of CVID, steroid therapy (1 mg/kg/day of prednisone) was initiated. Her fever immediately remitted, and after one month of treatment, the ESR was 10 mm/h, and ACE and CRP levels returned to normal (15.9 U/l and 0.65 mg/dl, respectively). Presently, at 18 months of follow-up the patient continues to be afebrile and practically asymptomatic; she has had no significant sinopulmonary infections and her pulmonary function remains stable. A recent immunologic evaluation was similar to previously reported values. Her current therapy includes 2.5 mg prednisone on alternate days, with the purpose of discontinuing it as soon as possible, and antifungal and antibiotic prophylaxis (itraconazole and cotrimoxazole) added to the monthly immunoglobulin replacement therapy (400-500 mg/kg/mo).
Discussion
This case presents a diagnostic dilemma in which prolonged fever without an apparent infectious or neoplastic cause appears in a patient with CVID and previously diagnosed liver, skin, intestinal and bone marrow non-caseating granulomatous disease. It is well known that sarcoid-like, non-caseating granulomas occur frequently in patients with
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CVID. Previous studies have reported a prevalence that ranges between 8% and 22% in CVID patients, but the actual incidence remains unknown (3, 6) . Nevertheless, the true relevance and pathogenic connection between these phenomena are still uncertain, and there is considerable controversy as to whether granulomatous disease seen in the context of CVID should be considered an atypical expression of sarcoidosis or a separate clinical entity, also described as a "sarcoidosis-like" CVID syndrome (6) (7) (8) .
The (3, 4) . Different autoimmune diseases are frequently associated with granulomatous CVID(over 50% of patients), particularly rheumatoid arthritis, haemolytic anaemia or primary biliary cirrhosis (Table 1) . This elevated co-occurrence also suggests some defect in cell-mediated immunity as a possible link between both entities (3) . (6, 8) . Caseating granulomas are quite rare and have been described in only a few patients with CVID, and pose the additional challenge of thoroughly ruling out infectious etiology (11, 13 (14) (15) (16) (17) (18) . For instance, fever is a common accompaniment of hepatic granulomas and occurs in as many as 75% of cases (16, 17) . It is a result of the release of IL-1 and other endogenous pyrogens from activated mononuclear phagocytes found in the granulomas. Once an infectious etiology has been excluded, oral prednisone generally results in a prompt defervescence and symptomatic improvement (16, 18, 19) . Nevertheless, in most series of FUO in the literature, granulomatous diseases make up less than 5% of diagnostic categories, usually labeled as "collagen diseases" or "inflammatory disorders" (14) . The (4) . In patients with severe hypersplenism or refractory haemolytic anaemia, splenectomy has frequently been performed in the past (8) . Prolonged corticotherapy has been the most widely studied treatment option, and appears helpful in reducing lymph node enlargement and splenomegaly, improving uveitis and hematological abnormalities (6) (7) (8) 20) . In most published cases of granulomatous CVID, the use of steroids was not associated with increased frequency of infections or worsening immunological function in patients on IVIG (6 (20, 21) , although further studies are needed to confirm the real usefulness of these new biological therapies.
underlying pathophysiology of the association remains obscure. The absence of granulomatous disease in other primary immunodeficiencies that are concomitant with antibody deficit (such as X-linked agammaglobulinaemia) has suggested that cellular immunity plays an important role. Antigen-processing defects or deregulation of inflammatory cytokine expression (IL-2 and IFN-y) by T-cells may lead to an inappropriate macrophage and epithelioid cell activation
As in sarcoidosis, the search for a hypothetical antigenic, infectious or environmental etiology for granulomatous disease in CVID has been unsuccessful (4). Patients with CVID might be more susceptible to certain transmissible agents who have been implicated as potential causes of sarcoidosis (e.g. mycobacteria, Borrelia burgdorferi, Propionibacterium acnes…). Nevertheless, some authors have suggested that HHV8 infection may be involved since patients with granulomatous disease and CVID are at high risk for developing lymphoproliferative disorders (9). HHV8 has the capacity to cause B-cell, lymphoproliferative diseases, particularly in secondary immunodeficiency (such as HIV-1 infection or bone marrow transplantation). There is a higher prevalence of HHV8 infection in CVID patients than in healthy controls and the prevalence is even higher in CVID patients with systemic granulomatous diseases (4)
.
